Efficacy of adipose—derived stromal vascular fraction in treatment of osteoarthritis: an experimental study.

Autor:	Moussa, Sherine Alaa El Din Mohamed, Zaki, M. Gamal El Din, Mohamed, Manal Osman, Abo Zeid, Asmaa A, Farrag, Dina A.
Předmět:	KNEE osteoarthritis FLOW cytometry ADIPOSE tissues ARTICULAR cartilage COMPUTER-assisted image analysis (Medicine) MESENCHYMAL stem cells POLYMERASE chain reaction KRUSKAL-Wallis Test TREATMENT effectiveness DESCRIPTIVE statistics MANN Whitney U Test INTRA-articular injections RATS EXPERIMENTAL design PROTEOLYTIC enzymes STROMAL cells ANIMAL experimentation CARTILAGE cells ONE-way analysis of variance COMPARATIVE studies DATA analysis software EVALUATION
Zdroj:	Egyptian Rheumatology & Rehabilitation; 3/25/2024, Vol. 51 Issue 1, p1-11, 11p
Abstrakt:	Background: Osteoarthritis OA is a common progressive disabling disease. Current research aims at finding therapies to prevent its progression. In this work, we assessed the therapeutic role of intra-articular injection of stromal vascular fraction SVF in collagenase induced knee OA in rats. Results: Post right Knee OA induction in 42 Wistar rats, histopathological examination and quantification of articular cartilage degeneration using Mankin's score revealed degenerative changes were significantly higher in untreated Group II compared to SVF treated Group III at 1 month (10.75 ± 0.50 and 2.50 ± 0.53, P = 0.001) and 2 months (8.50 ± 0.58, 0.50 ± 0.53, P = 0.001), respectively. Morphometric computerized image analysis revealed a significant difference between treated, untreated and healthy control group I regarding chondrocyte cellular count, articular cartilage thickness and optical density OD of the cartilage (P < 0.001). Group II contained the least chondrocyte cellular count. Also, articular cartilage thickness at 2 months was significantly less in Group II compared to SVF treated group (P < 0.001). The OD in Safranin-stained slides, as an indicator of proteoglycan content of the matrix, was highest in Group I followed by Group III and lowest in Group II with a highly significant difference between untreated and treated groups at 1 month (67.32 ± 4.25, 81.77 ± 3.09, P = 0.000) and 2 months (71.60 ± 3.49, 83.26 ± 5.47, P = 0.000), respectively. Conclusion: Treatment with adipose-derived SVF decreased the development of articular cartilage degenerative changes at early stages of induced OA in rats. Later, on follow-up, the preserved articular cartilage thickness, cellular count and increased proteoglycan content rendered SVF a promising regenerative therapy for Knee OA. [ABSTRACT FROM AUTHOR]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu Full text from SpringerLink